Business Context and Reporting Period
Company: ProKidney Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2025
Reporting Period: Quarter ended September 30, 2025
Context: The Company filed this report to announce its financial results for the quarter ended September 30, 2025, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q3 2025 results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 10, 2025) for actual financial figures, as they are not embedded in the 8-K text.
- Verify the Company's status as an Emerging Growth Company (indicated as checked in the filing).
- Confirm the trading symbol PROK on The Nasdaq Stock Market.
- Check for any forward-looking statements or updated guidance within the referenced press release.